Takeda to acquire GammaDelta to accelerate development of cell therapies for solid tumors

Takeda Pharmaceutical Co Ltd has exercised its option to acquire GammaDelta Therapeutics Limited, a company focused on exploiting the unique properties of gamma delta (γδ) T cells for immunotherapy. Through the acquisition, Takeda will obtain GammaDelta’s allogeneic variable delta 1 (Vδ1) gamma-delta (γδ) T cell therapy platforms, which includes both…

Related Keywords

United Kingdom ,Tim Haines ,Paolo Paoletti ,Christopher Arendt ,Takeda Pharmaceutical Co Ltd ,Gammadelta Therapeutics ,Gammadelta Therapeutics Limited ,Oncology Cell Therapy ,Therapeutic Area Unit ,Gammadelta Therapeutic ,Managing Partner ,